Estadisticas : Proliferation predicts failure-free survival in mantle cell lymphoma patients treated with rituximab plus hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone alternating with rituximab plus high-dose methotrexate and cytarabine Garcia, Mar
Visitas:439
266 ( Estados Unidos de América )
58 ( Singapur )
39 ( Hong kong )
23 ( Reino Unido )
12 ( Letonia )
9 ( Irlanda )
8 ( Brasil )
6 ( Alemania )
4 ( Austria )
3 ( China )
3 ( Canadá )
1 ( Bangladesh )
1 ( Marruecos )
1 ( Irak )
1 ( Turquía )
1 ( Vietnam )
1 ( Emiratos Árabes Unidos )
1 ( México )
1 ( España )
Descargas: 0